Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women

Lancet

Volumn 360, Issue 9337, 2002, Pages 925-926

  Spurdle, Amanda B ^a,g   Hopper, John L ^b   Chen, Xiaoqing ^a   McCredie, Margaret R E ^c,d   Giles, Graham G ^e   Newman, Beth ^f   Chenevix Trench, Georgia ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER RESEARCH DIVISION   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; MESSENGER RNA; PROHIBITIN; PROTEIN DERIVATIVE; THYMINE; UNCLASSIFIED DRUG; PROTEIN; REPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGE; ARTICLE; AUSTRIA; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; POLYMORPHIC LOCUS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; ALLELE; AUSTRALIA; BREAST TUMOR; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; RISK FACTOR;

ADULT; ALLELES; AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEINS; REPRESSOR PROTEINS; RISK FACTORS;

EID: 0037151795     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11043-9     Document Type: Article

References (5)

1. Wang S., Nath N., Adlam M., Chellappan S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 18:1999;3501-3510.
2. Jupe E.R., Liu X.T., Kiehlbauch J.L., McClung J.K., Dell'Orco R.T. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations. Cell Growth Differ. 7:1996;871-878.
3. Jupe E.R., Badgett A.A., Neas B.R., et al. Single nucleotide polymorphism in prohibitin 3′ untranslated region and breast-cancer susceptibility. Lancet. 357:2001;1588-1589.
4. Spurdle A.B., Hopper J.L., Dite G.S., et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst. 92:2000;1674-1681.
5. Hopper J.L., Chenevix-Trench G., Jolley D.J., et al. Design and analysis issues in a population-based case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 26:1999;95-100.